Clorox Q3 net sales down 5% to $1.81B; adjusted EPS up 13% to $1.71

CLOROX CO /DE/

2024-Q3 EPS reported $0.52 revenue$5,190,000,000

Net sales fell 5% to $1.81B; organic sales up 2% despite cyberattack disruptions.
Diluted EPS loss of $0.41 vs loss of $1.71 YoY; adjusted EPS rose 13% to $1.71.
Gross margin expanded 40 bps to 42.2% on pricing and cost savings.
YTD operating cash flow $355M, down 51%; free cash flow $224M vs $584M.
Divested Argentina business on Mar 20; expects full distribution recovery by Q4 end.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CLOROX CO /DE/ reported third quarter ended March 31, 2024 results: revenue $1.81 billion, EPS ($0.41) per diluted share.

Period: third quarter ended March 31, 2024
Revenue: $1.81 billion
EPS: ($0.41) per diluted share
Result: reported results

Exact text from the filing

20, 2024 divestiture of the company's Argentina business and all comparisons are with the third quarter of fiscal year 2023 unless otherwise stated. • Net sales decreased 5% to $1.81 billion compared to a 6% net sales increase in the year-ago quarter. The decrease was driven largely by lower volume from temporary distribution losses resulting from the widescale

View on SEC.gov

379 earnings releases filed in the last 30 days. Browse all earnings releases →

CLOROX CO /DE/ filing history →

Source: SEC EDGAR

accession 0000021076-24-000014

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.